Life Sciences Information Management and e-Submissions Software Suite
Early stage, emerging growth company. Perfect tuck-in acquisition opportunity for software company selling to pharmaceutical and/or medical device manufacturers. Pharmaceutical manufacturers currently buy this application software to manage all regulatory submissions processes, and choose it for drag-and-drop ease of use and comprehensiveness. Software as a Service (SaaS) company serving the highly regulated, international pharmaceutical, biotech, medical device and equipment markets from its bi-coastal U.S. and China operations. Turn key, Java-based, complete submissions engine offering drag-and-drop simplicity that can be integrated into other life sciences vertical software applications. Company asserts that they hold a technological lead over competition, supporting more Clinical Data Interchange Standards Consortium (CDISC) standards than anyone (9 of 12), as the technology was built to CDISC specifications. High brand profile In key pharma industry associations, such as Drug Information Association (DIA), RAPS, ANSI, GPhA, etc. Company is being offered un-priced to qualified acquirers. Confidentiality Agreement and potentially other documentation will be required to review Informational Memorandum.
Please refer to listing ID: ABI# 2872
Industry:
Technology
Industry Segment:
Software and Internet Developers
Geography:
United States > California
Gross Revenue:
$918,000
Cash Flow:
$150,000
Value of Equipment:
$15,600 (Included in Asking Price)
Year Established:
2005
Number of Employees:
10 full time -
Mgmt. Training/Support:
Seller willing to provide support/training (very flexible), and open to possibility of joining acquiring corporation (life sciences regulatory, I.T. function).
Reason For Selling:
Best of breed software product needs bigger company resources
Facilities:
Company operates from two leased offices in top U.S. technology centers of the East & West Coasts (sales, admin) + a leased office in Beijing, China (programming, customer support). Would be easy to fold and move U.S. operation into acquirer's operation. Company has operated in Beijing 6 yrs, very knowledgeable of how to be successful there; has established relationship and company credibility with Chinese equivalent of U.S. F.D.A.
Market Outlook/Competition:
Pharmaceutical and medical device regulatory agencies such as the U.S. Food & Drug Admin. (FDA) and intl. equivalents are mandating that companies submit all regulatory data electronically, in accordance with specific protocols. In 2013 the FDA will accept ONLY CDISC-HL7 XML format. This company bet correctly a few years ago that CDISC would be the winning standard, and developed all software to CDISC standards. Company believes they alone offer a complete solution for data and document mngmt, work flow and retention for ALL electronic submissions.
